CMAJ • November 23, 2004; 171 (11). doi:10.1503/cmaj.1040398.
© 2004 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, C.-M.
Right arrow Articles by Yuen, K.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, C.-M.
Right arrow Articles by Yuen, K.-Y.
Related Collections
Right arrow Severe Acute Respiratory Syndrome (SARS)
Right arrowRelated Articles


Research
Recherche

Initial viral load and the outcomes of SARS

Chung-Ming Chu, Leo L.M. Poon, Vincent C.C. Cheng, Kin-Sang Chan, Ivan F.N. Hung, Maureen M.L. Wong, Kwok-Hung Chan, Wah-Shing Leung, Bone S.F. Tang, Veronica L. Chan, Woon-Leung Ng, Tiong-Chee Sim, Ping-Wing Ng, Kin-Ip Law, Doris M.W. Tse, Joseph S.M. Peiris and Kwok-Yung Yuen

From the Department of Medicine and Geriatrics (Chu, K.S. Chan, Leung, V.L. Chan, W.L. Ng, Sim, P.W. Ng) and the Intensive Care Unit (Law), United Christian Hospital, Hong Kong Special Administrative Region, China; the Department of Microbiology, Queen Mary Hospital, The University of Hong Kong (Poon, Cheng, Hung, Tang, K.H. Chan, Peiris, Yuen), Hong Kong Special Administrative Region, China; and the Department of Medicine and Geriatrics, Caritas Medical Centre (Wong, Tse), Hong Kong Special Administrative Region, China

Background: Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus. It may progress to respiratory failure, and a significant proportion of patients die. Preliminary data suggest that a high viral load of the SARS coronavirus is associated with adverse outcomes in the intensive care unit, but the relation of viral load to survival is unclear.

Methods: We prospectively studied an inception cohort of 133 patients with virologically confirmed SARS who were admitted to 2 general acute care hospitals in Hong Kong from Mar. 24 to May 4, 2003. The patients were followed until death or for a minimum of 90 days. We used Cox proportional hazard modelling to analyze potential predictors of survival recorded at the time of presentation, including viral load from nasopharyngeal specimens (measured by quantitative reverse transcriptase polymerase chain reaction [PCR] of the SARS-associated coronavirus).

Results: Thirty-two patients (24.1%) met the criteria for acute respiratory distress syndrome, and 24 patients (18.0%) died. The following baseline factors were independently associated with worse survival: older age (61–80 years) (adjusted hazard ratio [HR] 5.24, 95% confidence interval [CI] 2.03–13.53), presence of an active comorbid condition (adjusted HR 3.36, 95% CI 1.44–7.82) and higher initial viral load of SARS coronavirus, according to quantitative PCR of nasopharyngeal specimens (adjusted HR 1.21 per log10 increase in number of RNA copies per millilitre, 95% CI 1.06–1.39).

Interpretation: We found preliminary evidence that higher initial viral load is independently associated with worse prognosis in SARS. Mortality data for patients with SARS should be interpreted in light of age, comorbidity and viral load. These considerations will be important in future studies of SARS.



Related Articles

SARS outbreak in the Greater Toronto Area: the emergency department experience
Bjug Borgundvaag, Howard Ovens, Brian Goldman, Michael Schull, Tim Rutledge, Kathy Boutis, Sharon Walmsley, Allison McGeer, Anita Rachlis, and Carolyn Farquarson
Can. Med. Assoc. J. 2004 171: 1342-1344. [Full Text] [PDF]

The impact of SARS on a tertiary care pediatric emergency department
Kathy Boutis, Derek Stephens, Kelvin Lam, Wendy J. Ungar, and Suzanne Schuh
Can. Med. Assoc. J. 2004 171: 1353-1358. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
PediatricsHome page
A. Bitnun, S. Read, R. Tellier, M. Petric, and S. E. Richardson
Severe Acute Respiratory Syndrome-Associated Coronavirus Infection in Toronto Children: A Second Look
Pediatrics, January 1, 2009; 123(1): 97 - 101.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. K.-f. Li, H. Wu, H. Yan, S. Ma, L. Wang, M. Zhang, X. Tang, N. J. Temperton, R. A. Weiss, J. M. Brenchley, et al.
T Cell Responses to Whole SARS Coronavirus in Humans
J. Immunol., October 15, 2008; 181(8): 5490 - 5500.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen
Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection
Clin. Microbiol. Rev., October 1, 2007; 20(4): 660 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. L. DeDiego, E. Alvarez, F. Almazan, M. T. Rejas, E. Lamirande, A. Roberts, W.-J. Shieh, S. R. Zaki, K. Subbarao, and L. Enjuanes
A Severe Acute Respiratory Syndrome Coronavirus That Lacks the E Gene Is Attenuated In Vitro and In Vivo
J. Virol., February 15, 2007; 81(4): 1701 - 1713.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. T.K. Pang, T. C.W. Poon, K.C. A. Chan, N. L.S. Lee, R. W.K. Chiu, Y.-K. Tong, R. M.Y. Wong, S. S.C. Chim, S. M. Ngai, J. J.Y. Sung, et al.
Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome
Clin. Chem., March 1, 2006; 52(3): 421 - 429.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. S.Y. Wong and K.-y. Yuen
Nasopharyngeal Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus RNA in Health-Care Workers
Chest, January 1, 2006; 129(1): 12 - 13.
[Full Text] [PDF]


Home page
J. Virol.Home page
B. Yount, R. S. Roberts, A. C. Sims, D. Deming, M. B. Frieman, J. Sparks, M. R. Denison, N. Davis, and R. S. Baric
Severe Acute Respiratory Syndrome Coronavirus Group-Specific Open Reading Frames Encode Nonessential Functions for Replication in Cell Cultures and Mice
J. Virol., December 1, 2005; 79(23): 14909 - 14922.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C.-M. Chu and K.-S. Chan
Ribavarin Should Be Tested in Clinical Trials in Combination With Other Antiviral Agents for Severe Acute Respiratory Syndrome
Chest, December 1, 2005; 128(6): 4050 - 4050.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
L. L. M. Poon, B. W. Y. Wong, K. H. Chan, S. S. F. Ng, K. Y. Yuen, Y. Guan, and J. S. M. Peiris
Evaluation of Real-Time Reverse Transcriptase PCR and Real-Time Loop-Mediated Amplification Assays for Severe Acute Respiratory Syndrome Coronavirus Detection
J. Clin. Microbiol., July 1, 2005; 43(7): 3457 - 3459.
[Abstract] [Full Text] [PDF]